Search

Your search keyword '"Morii I."' showing total 99 results

Search Constraints

Start Over You searched for: Author "Morii I." Remove constraint Author: "Morii I."
99 results on '"Morii I."'

Search Results

1. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

4. Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction

10. Abnormal glucose tolerance, not small vessel diameter, is a determinant of long-term prognosis in patients treated with balloon coronary angioplasty.

11. Is preinfarction angina related to the presence or absence of coronary plaque rupture?

12. Increased plasma adrenomedullin levels in patients with acute myocardial infarction in proportion to the clinical severity

13. Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction

14. Antiinflammatory therapy with canakinumab for atherosclerotic disease

15. IMAGE CARDIO MED: Oppression of left main trunk due to pseudoaneurysm with graft detachment in patients with Behcet disease previously treated by the Bentall procedure.

16. Usefulness of serum troponin T levels on day three or four in predicting survival after acute myocardial infarction.

17. Previous angina reduces in-hospital death in patients with acute myocardial infarction.

18. Effect on survival of previous angina pectoris after acute myocardial infarction.

19. Efficacy and Safety of Rivaroxaban, Apixaban, and Edoxaban for Nonvalvular Atrial Fibrillation Based on Blood Coagulation Activity and Drug Plasma Concentration: SETtsu and North Osaka Multicenter Direct Oral AntiCoagulant (SET DOAC) Registry.

20. Klebsiella Pneumoniae Invasive Syndrome With Thoracic Aortic Pseudoaneurysm.

21. Letter by Suwa et al Regarding Article, "Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial".

23. Prolonged delirium during hospitalization is associated with worse long-term and short-term outcomes in patients with acute heart failure.

25. Safety and Efficacy Re-Evaluation of Edoxaban and Rivaroxaban Dosing With Plasma Concentration Monitoring in Non-Valvular Atrial Fibrillation: With Observations of On-Label and Off-Label Dosing.

26. Dose adjustment based on the plasma level measurement used anti-FXa chromogenic assay on the use of non-vitamin K antagonist oral anticoagulants (NOACs) improved the overall benefit of NOACs dosing in patients with atrial fibrillation.

27. Effects of partial sleep deprivation after prolonged exercise on metabolic responses and exercise performance on the following day.

28. Rivaroxaban or Apixaban for Non-Valvular Atrial Fibrillation - Efficacy and Safety of Off-Label Under-Dosing According to Plasma Concentration.

29. Inhibiting the MCM8-9 complex selectively sensitizes cancer cells to cisplatin and olaparib.

30. Does Treatment of Impaired Glucose Tolerance Improve Cardiovascular Outcomes in Patients with Previous Myocardial Infarction?

32. Acute myocardial infarction and cardiogenic shock caused by a huge right Valsalva sinus aneurysm.

33. Decreased serum ghrelin levels in patients with acute myocardial infarction.

34. [Intra-aortic balloon pumping].

35. The first clinical pilot study of intravenous adrenomedullin administration in patients with acute myocardial infarction.

37. Significant association of coronary artery calcification in stent delivery route with restenosis after sirolimus-eluting stent implantation.

38. Improved long-term prognosis of elderly women in the era of sirolimus-eluting stents.

39. Significant association between neutrophil aggregation in aspirated thrombus and myocardial damage in patients with ST-segment elevation acute myocardial infarction.

40. Impact of metabolic syndrome on the long-term survival of patients with acute myocardial infarction: potential association with C-reactive protein.

41. Role of transthoracic Doppler-determined coronary flow reserve in patients with chest pain.

42. Prevention of life-threatening ventricular tachyarrhythmia by a novel and pure class-III agent, nifekalant hydrochloride.

43. Postinfarction cardiac rupture despite immediate reperfusion therapy in a patient with severe aortic valve stenosis.

44. Favourable clinical outcome in patients with cardiogenic shock due to fulminant myocarditis supported by percutaneous extracorporeal membrane oxygenation.

45. Comparison of pharmacokinetics of the sirolimus-eluting stent in Japanese patients with those in American patients.

46. Quantitative coronary angiographic studies of patients with angina pectoris and impaired glucose tolerance.

47. [Fulminant myocarditis causing severe left heart failure and massive thrombus formation following cardiac tamponade: a case report].

48. Three cases of acute myocardial infarction due to coronary embolism: treatment using a thrombus aspiration device.

49. Local delivery of argatroban for the prevention of restenosis after coronary balloon angioplasty: a prospective randomized pilot study.

50. [Acute myocardial infarction due to septic emboli in a patient with severe pneumonia: a case report].

Catalog

Books, media, physical & digital resources